1.Development and manufacture of WDJ-CP-1 dermabrasive cosmetic instrument
Zhun LI ; Yiqun CHEN ; Haitao YU ; Zhihua CHEN ; Jiqiang SUI ; Na XU
Chinese Medical Equipment Journal 2003;0(10):-
Objective To develop and manufacture new-type dermabrasive cosmetic instrument and investigate its clinical value.Methods WDJ-CP-I dermabrasive cosmetic instrument was developed by using medical brushless magdyno and then was applied to 296 cases.Results WDJ-CP-I dermabrasive cosmetic instrument had such advantages as small volume,lower noise,long duration of life,simple operation,high-temperature & high-pressure sterilization,safety,high dermabrasive rate,ect.Conclusion WDJ-CP-I dermabrasive cosmetic instrument is a good tool for dermabrasion and is worth popularizing.
2.The prevention of crush syndrome related medical problems after earthquake
Li WANG ; Qiang HE ; Guisen LI ; Fang WANG ; Xiuling CHEN ; Dihua ZHANG ; Lei WANG ; Zhun SUI
Chinese Journal of Internal Medicine 2008;47(9):711-714
Crush syndrome in patients rescued from earthquake is a complex clinical syndrome with many medical conditions.The most complications are hyperkalemia,acute kidney injury,shock,infection,ARDS,malnutrition and multiorgan dysfunction.Managing these critical issues appropriately is essential for effective treatment of the crush syndrome.
3. Arterial stiffness and its impact on prognosis in patients with stage 3-5 chronic kidney disease(pre-dialysis)
Li-min JIA ; Xin ZHANG ; Mi WANG ; Zhun SUI ; Li BAI ; Li ZUO ; Mei WANG
Chinese Journal of Practical Internal Medicine 2019;39(12):1053-1059
OBJECTIVE: To assess the impact of arterial stiffness on prognosis in patients with chronic kidney disease(CKD)stages 3-5(pre-dialysis).METHODS: 141 patients suffered from chronic kidney disease(CKD)stages 3-5 pre-dialysis were enrolled in this study between April 2006 and November 2010.Automatic pulse wave velocity(PWV)measuring system was used to examine carotid-femoral pulse wave velocity(CFPWV).According to CFPWV level,we divided the patients into elevated CFPWV group(CFPWV ≥12 m/s)and the normal group(CFPWV<12 m/s).Patients were followed up for the occurrence of cardiovascular event,cardiovascular death and all-cause death.Kaplan-Meier methods were used for survival analysis and Cox's proportional hazard regression model were used to analyze risk factors.RESULTS: Two groups were followed-up(93.72±47.93)months.The incidences of cardiac-cerebral vascular event,cardiac-cerebral vascular death and all-cause death were higher in high CFPWV level groups(62.2%vs.21.6%,56.7%vs.15.7%,64.4%vs.19.6%,P<0.05).The level of CFPWV was higher in patients with cardiac-cerebral vascular event,cardiac-cerebral vascular death and all-cause death than those without those events[(15.31±3.41)m/s vs.(12.08±2.94)m/s,(15.66±3.40)m/s vs.(12.14±2.88)m/s,(15.38±3.38)m/s vs.(11.97±2.87)m/s,P<0.01].Kaplan-Meier curve for overall survivals and cardiac-cerebral vascular event free survivals showed a significant distinct between high and normal CFPWV level groups,suggesting that the incidence of cardiac-cerebral vascular events,cardiac-cerebral vascular mortality and all-cause mortality were significantly higher in high CFPWV level group than in normal CFPWV group(P=0.000).Multivariate Cox regression analysis revealed that increased CFPWV and commencing dialysis were the independent risk factors for cardiac-cerebral vascular event,increased CFPWV and CRP and decreased ALB and commencing dialysis were the independent risk factors for cardiac-cerebral vascular mortality and all-cause mortality(P<0.05).CONCLUSION: The levels of CFPWV in pre-dialysis chronic kidney disease(CKD)stage 3-5 patients increases significantly.The incidence of cardiac-cerebral vascular events,cardiac-cerebral vascular mortality and all-cause mortality are significantly higher in elevated CFPWV group than those of normal group in patients with CKD G3-5.The elevated CFPWV is one of independent risk factors of cardiac-cerebral vascular event,cardiac-cerebral vascular mortality and all-cause mortality in patients with pre-dialysis chronic kidney disease.